URGN · Company research
UroGen Pharma Ltd. (URGN): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| A bladder cancer drug candidate had a 77.8% complete response rate at three months. - Stock Titan | A bladder cancer drug candidate had a 77.8% complete response rate at three months. Stock Titan | View source ↗ | Stock Titan | Oct 19, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Oct 19, 2026 | neutral | 0 | 0.6 |
| UroGen Pharma: An Emerging GARP Stock - Seeking Alpha | UroGen Pharma: An Emerging GARP Stock Seeking Alpha | View source ↗ | Seeking Alpha | Oct 13, 2026 | neutral | 0 | 0.6 |
| To cover equity-award taxes, UroGen Pharma (URGN) officer proposes selling 2,202 shares. - Stock Titan | To cover equity-award taxes, UroGen Pharma (URGN) officer proposes selling 2,202 shares. Stock Titan | View source ↗ | Stock Titan | Oct 9, 2026 | neutral | 0 | 0.6 |
| $URGN stock is down 13% today. Here's what we see in our data. - Quiver Quantitative | $URGN stock is down 13% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 8, 2026 | neutral | 0 | 0.6 |
| UroGen Pharma (NasdaqGM:URGN) Stock Forecast & Analyst Predictions - Simply Wall Street | UroGen Pharma (NasdaqGM:URGN) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 7, 2026 | neutral | 0 | 0.6 |
| UroGen Pharma Ltd. (URGN) stock price, news, quote and history - Yahoo Finance Australia | UroGen Pharma Ltd. (URGN) stock price, news, quote and history Yahoo Finance Australia | View source ↗ | Yahoo Finance Australia | Oct 1, 2026 | neutral | 0 | 0.6 |
| Here's Why You Should Add URGN Stock to Your Portfolio Now - Yahoo Finance | Here's Why You Should Add URGN Stock to Your Portfolio Now Yahoo Finance | View source ↗ | Yahoo Finance | Sep 30, 2026 | neutral | 0 | 0.6 |
| Here's Why You Should Add URGN Stock to Your Portfolio Now - TradingView | Here's Why You Should Add URGN Stock to Your Portfolio Now TradingView | View source ↗ | TradingView | Sep 30, 2026 | neutral | 0 | 0.6 |
| UroGen Pharma (URGN) Stock Looks Fairly Valued On Its Sales Base - Yahoo Finance | UroGen Pharma (URGN) Stock Looks Fairly Valued On Its Sales Base Yahoo Finance | View source ↗ | Yahoo Finance | Sep 25, 2026 | neutral | 0 | 0.6 |
| UroGen Pharma (URGN) Stock Looks About Right As Sales Catch Up - Simply Wall Street | UroGen Pharma (URGN) Stock Looks About Right As Sales Catch Up Simply Wall Street | View source ↗ | Simply Wall Street | Sep 24, 2026 | neutral | 0 | 0.6 |
| UroGen (NASDAQ: URGN) officer sold $750K in stock, plans more - Stock Titan | UroGen (NASDAQ: URGN) officer sold $750K in stock, plans more Stock Titan | View source ↗ | Stock Titan | Aug 20, 2026 | neutral | 0 | 0.6 |
| URGN Stock Jumps As Street Hikes Targets On Patent Wins - Timothy Sykes | URGN Stock Jumps As Street Hikes Targets On Patent Wins Timothy Sykes | View source ↗ | Timothy Sykes | Aug 5, 2026 | neutral | 0 | 0.6 |
| URGN Forecast — Price Target — Prediction for 2027 - TradingView | URGN Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| Insider Sale: Chief Medical Officer of $URGN Sells 5,222 Shares - Quiver Quantitative | Insider Sale: Chief Medical Officer of $URGN Sells 5,222 Shares Quiver Quantitative | View source ↗ | Quiver Quantitative | Jun 9, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.